Search details
1.
Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database.
Int J Gynecol Cancer
; 33(8): 1237-1246, 2023 08 07.
Article
in English
| MEDLINE | ID: mdl-37164363
2.
Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study.
Thorax
; 77(7): 721-723, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35277447
3.
Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.
Pharmacoepidemiol Drug Saf
; 31(11): 1199-1205, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35689298
4.
Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma.
Cytokine
; 126: 154868, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31629110
5.
Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.
Int J Clin Oncol
; 23(2): 389-399, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29181651
6.
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
Chemotherapy
; 62(4): 246-255, 2017.
Article
in English
| MEDLINE | ID: mdl-28472798
7.
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma.
Lancet Oncol
; 18(5): e241-e242, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28495287
8.
Facial palsy induced by immune checkpoint blockade: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data.
Int Immunopharmacol
; 125(Pt B): 111184, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37952483
9.
SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
Acta Diabetol
; 60(3): 401-411, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36576563
10.
A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab.
Expert Opin Drug Saf
; 22(4): 339-342, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36178002
11.
Cost-effectiveness analysis of nivolumab plus cabozantinib versus sunitinib as first-line therapy in advanced renal cell carcinoma.
Immunotherapy
; 14(11): 859-869, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35754404
12.
Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data.
Int Immunopharmacol
; 110: 109053, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35978507
13.
Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients.
Front Pharmacol
; 13: 891648, 2022.
Article
in English
| MEDLINE | ID: mdl-35873585
14.
Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database.
EClinicalMedicine
; 37: 100951, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34386743
15.
Global research trends of drug-induced liver injury (DILI) in the past two decades: a bibliometric and visualized study.
Ann Palliat Med
; 10(8): 8651-8664, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34328016
16.
Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis.
Expert Opin Drug Saf
; 19(5): 617-623, 2020 May.
Article
in English
| MEDLINE | ID: mdl-31955620
17.
Developing an isotope dilution UHPLC-MS/MS method to quantify linezolid in human plasma: application to therapeutic drug monitoring.
Bioanalysis
; 12(14): 991-1001, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32697609
18.
Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map.
Lancet Diabetes Endocrinol
; 8(3): 192-205, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32006518
19.
Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis.
Expert Rev Anticancer Ther
; 18(2): 193-198, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29257709
20.
Insulin-like growth factor-1 activates PI3K/Akt signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury.
Br J Pharmacol
; 175(1): 125-139, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29057462